Search Results - "BIK TO, L"

Refine Results
  1. 1

    How I treat patients who mobilize hematopoietic stem cells poorly by To, L. Bik, Levesque, Jean-Pierre, Herbert, Kirsten E.

    Published in Blood (27-10-2011)
    “…Transplantation with 2-5 × 106 mobilized CD34+cells/kg body weight lowers transplantation costs and mortality. Mobilization is most commonly performed with…”
    Get full text
    Journal Article
  2. 2

    Expression of the chemokine receptor CCR1 promotes the dissemination of multiple myeloma plasma cells in vivo by Zeissig, Mara N, Hewett, Duncan R, Panagopoulos, Vasilios, Mrozik, Krzysztof M, To, L Bik, Croucher, Peter I, Zannettino, Andrew C W, Vandyke, Kate

    Published in Haematologica (Roma) (01-12-2021)
    “…Multiple myeloma (MM) disease progression is dependent on the ability of MM plasma cells (PCs) to egress from the bone marrow (BM), enter the circulation and…”
    Get full text
    Journal Article
  3. 3

    HIF-2α Promotes Dissemination of Plasma Cells in Multiple Myeloma by Regulating CXCL12/CXCR4 and CCR1 by Vandyke, Kate, Zeissig, Mara N, Hewett, Duncan R, Martin, Sally K, Mrozik, Krzysztof M, Cheong, Chee Man, Diamond, Peter, To, L Bik, Gronthos, Stan, Peet, Daniel J, Croucher, Peter I, Zannettino, Andrew C W

    Published in Cancer research (Chicago, Ill.) (15-10-2017)
    “…Disease progression and relapse in multiple myeloma is dependent on the ability of the multiple myeloma plasma cells (PC) to reenter the circulation and…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Dasatinib Cellular Uptake and Efflux in Chronic Myeloid Leukemia Cells: Therapeutic Implications by HIWASE, Devendra K, SAUNDERS, Verity, HUGHES, Timothy P, WHITE, Deborah L, HEWETT, Duncan, FREDE, Amity, ZRIM, Stephanie, DANG, Phuong, EADIE, Laura, BIK TO, L, MELO, Junia, KUMAR, Sharad

    Published in Clinical cancer research (15-06-2008)
    “…Purpose: The organic cation transporter OCT-1 mediates active transport of imatinib. We recently showed that low OCT-1 activity is a major contributor to…”
    Get full text
    Journal Article
  6. 6

    An optimized algorithm for detecting and annotating regional differential methylation by Li, Sheng, Garrett-Bakelman, Francine E, Akalin, Altuna, Zumbo, Paul, Levine, Ross, To, Bik L, Lewis, Ian D, Brown, Anna L, D'Andrea, Richard J, Melnick, Ari, Mason, Christopher E

    Published in BMC bioinformatics (10-04-2013)
    “…DNA methylation profiling reveals important differentially methylated regions (DMRs) of the genome that are altered during development or that are perturbed by…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10

    Long-term imatinib therapy promotes bone formation in CML patients by Fitter, Stephen, Dewar, Andrea L., Kostakis, Panagiota, To, L. Bik, Hughes, Timothy P., Roberts, Marion M., Lynch, Kevin, Vernon-Roberts, Barrie, Zannettino, Andrew C.W.

    Published in Blood (01-03-2008)
    “…Imatinib inhibits tyrosine kinases important in osteoclast (c-Fms) and osteoblast (platelet-derived growth factor receptor [PDGF-R], c-Abl) function,…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Targeted Disruption of the CXCL12/CXCR4 Axis Inhibits Osteolysis in a Murine Model of Myeloma‐Associated Bone Loss by Diamond, Peter, Labrinidis, Agatha, Martin, Sally K, Farrugia, Amanda N, Gronthos, Stan, To, L Bik, Fujii, Nobutaka, O'Loughlin, Peter D, Evdokiou, Andreas, Zannettino, Andrew CW

    Published in Journal of bone and mineral research (01-07-2009)
    “…The plasma cell (PC) malignancy, multiple myeloma (MM), is unique among hematological malignancies in its capacity to cause osteoclast (OC)‐mediated skeletal…”
    Get full text
    Journal Article
  13. 13

    Cotransplantation of Placental Mesenchymal Stromal Cells Enhances Single and Double Cord Blood Engraftment in Nonobese Diabetic/Severe Combined Immune Deficient Mice by Hiwase, Smita D, Dyson, Pamela G, To, L. Bik, Lewis, Ian D.

    Published in Stem cells (Dayton, Ohio) (01-09-2009)
    “…Limited cell numbers in a unit restricts cord blood transplantation (CBT) in adults. We evaluated whether cotransplantation of placental mesenchymal stromal…”
    Get full text
    Journal Article
  14. 14

    Measurement of In Vivo BCR-ABL Kinase Inhibition to Monitor Imatinib-Induced Target Blockade and Predict Response in Chronic Myeloid Leukemia by WHITE, Deborah, SAUNDERS, Verity, GRIGG, Andrew, ARTHUR, Chris, FILSHIE, Robin, LEAHY, Michael F, LYNCH, Kevin, BIK TO, L, HUGHES, Timothy

    Published in Journal of clinical oncology (01-10-2007)
    “…Intrinsic sensitivity to imatinib, based on measurement of inhibitory concentration 50% for imatinib, is variable in untreated patients with chronic myeloid…”
    Get full text
    Journal Article
  15. 15

    Imatinib as a potential antiresorptive therapy for bone disease by Dewar, Andrea L., Farrugia, Amanda N., Condina, Mark R., Bik To, L., Hughes, Timothy P., Vernon-Roberts, Barrie, Zannettino, Andrew C.W.

    Published in Blood (01-06-2006)
    “…Osteoclasts (OCs) are large multinucleated cells derived from progenitor cells of the monocyte-macrophage lineage. Signal transduction via the…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Results of a phase 2 study of pacritinib (SB1518), a JAK2/JAK2(V617F) inhibitor, in patients with myelofibrosis by Komrokji, Rami S., Seymour, John F., Roberts, Andrew W., Wadleigh, Martha, To, L. Bik, Scherber, Robyn, Turba, Elyce, Dorr, Andrew, Zhu, Joy, Wang, Lixia, Granston, Tanya, Campbell, Mary S., Mesa, Ruben A.

    Published in Blood (23-04-2015)
    “…Pacritinib (SB1518) is a Janus kinase 2 (JAK2), JAK2(V617F), and Fms-like tyrosine kinase 3 inhibitor that does not inhibit JAK1. It demonstrated a favorable…”
    Get full text
    Journal Article
  18. 18

    Dynamic evolution of clonal epialleles revealed by methclone by Li, Sheng, Garrett-Bakelman, Francine, Perl, Alexander E, Luger, Selina M, Zhang, Chao, To, Bik L, Lewis, Ian D, Brown, Anna L, D'Andrea, Richard J, Ross, M Elizabeth, Levine, Ross, Carroll, Martin, Melnick, Ari, Mason, Christopher E

    Published in Genome biology (27-09-2014)
    “…We describe methclone, a novel method to identify epigenetic loci that harbor large changes in the clonality of their epialleles (epigenetic alleles)…”
    Get full text
    Journal Article
  19. 19

    Mobilisation strategies for normal and malignant cells by To, L. Bik, Levesque, Jean-Pierre, Herbert, Kirsten E., Winkler, Ingrid G., Bendall, Linda J., Hiwase, Devendra K., Antonenas, Vicki, Rice, Alison M., Gottlieb, David, Mills, Anthony K., Rasko, John E.J., Larsen, Stephen, Beligaswatte, Ashanka, Nilsson, Susan K., Cooney, Julian P., Cambareri, Antony C., Lewis, Ian D.

    Published in Pathology (01-10-2011)
    “…This review evaluates the latest information on the mobilisation of haemopoietic stem cells for transplantation, with the focus on what is the current best…”
    Get full text
    Journal Article
  20. 20